Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Sheel Biotech Ltd (SHEEL) is currently trading at 68.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Sheel Biotech Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Sheel Biotech Ltd has traded between a low of ₹37.80 and a high of ₹95.55. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Sheel Biotech Ltd has a market capitalization of approximately 138.40. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Sheel Biotech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 11.77 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 138.40 Cr, Sheel Biotech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Sheel Biotech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Sheel Biotech Ltd is 11.77. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The IPO opened on 30 September 2025 and closed on 3 October 2025, with allotment stated for 6 October 2025.
Industrial Manufacturing
Industrial Products
138 Cr
Low Risk
11.8
46.6
0.4
1.1
95.55
37.80
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
3
Neutral
8
Bullish
3
Bearish
19
Neutral
13
Bullish
14
Bearish
16
Neutral
5
Bullish
11
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
2106.85 | 141 Cr | 84.37 | 6.19 | 0.47 | 7.35 | 9.92 | 4.06 | ||
124.05 | 141 Cr | 11.78 | 1.46 | 0.00 | 12.42 | 15.24 | 7.69 | ||
68.00 | 138 Cr | 11.77 | 1.09 | 0.00 | 9.26 | 11.72 | 8.07 | ||
55.00 | 136 Cr | 28.48 | 1.42 | 0.00 | 4.99 | 6.61 | 2.88 | ||
247.00 | 132 Cr | 64.20 | 6.09 | 0.00 | 9.49 | 12.50 | 3.14 | ||
94.90 | 130 Cr | 11.76 | 1.66 | 0.00 | 14.11 | 14.99 | 9.49 | ||
| Median: 6 Co. | — | 109.47 | 137 Cr | 20.13 | 1.56 | 0.00 | 9.37 | 12.11 | 5.87 |
